erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
air pollution in the united kingdom has been illegally high since 2010, leading to the premature deaths of 23,500 people each year,
.
"it has been a long two years and throughout that time the western trust has not been assisting us in trying to understand the circumstances around our mother's death.
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.